Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

How EvoLV Differentiates in the Life Sciences Consulting Industry

Jun 13, 2026By Sreejith Kanhirangadan

SK

Innovative Approaches in Life Sciences Consulting

In the competitive world of life sciences consulting, EvoLV sets itself apart through a commitment to innovation and tailored solutions. By leveraging cutting-edge technology and industry expertise, EvoLV provides clients with transformative strategies that drive success. This focus on personalized service and advanced methodologies ensures that EvoLV remains at the forefront of the industry.

One of the core ways EvoLV differentiates itself is through its emphasis on innovation-driven strategies. The company consistently integrates the latest technological advancements into its consulting practices, allowing clients to benefit from state-of-the-art solutions. This approach not only enhances the effectiveness of their services but also empowers clients to reach new heights in their respective fields.

innovation consulting

Tailored Solutions for Unique Challenges

EvoLV understands that no two clients are the same, which is why they prioritize the development of customized solutions for each project. By taking the time to thoroughly understand the unique challenges and goals of their clients, EvoLV crafts strategies that are specifically designed to meet their needs. This bespoke approach ensures optimal results and long-term success.

The company employs a collaborative process, working closely with clients to identify key areas of improvement and potential opportunities. This partnership model fosters trust and transparency, enabling EvoLV to deliver solutions that are both effective and sustainable.

team collaboration

Expertise Across the Life Sciences Spectrum

With a team of seasoned professionals, EvoLV boasts extensive expertise across the entire life sciences spectrum. From pharmaceuticals and biotechnology to medical devices and diagnostics, EvoLV's consultants bring a wealth of knowledge and experience to every engagement. This broad expertise allows the company to address a diverse range of challenges, providing clients with comprehensive support.

Additionally, EvoLV invests in continuous learning and professional development, ensuring that its team remains at the cutting edge of industry trends and advancements. This commitment to excellence is reflected in the quality of their work and the success of their clients.

life sciences expertise

Commitment to Regulatory Compliance

In the life sciences industry, regulatory compliance is paramount. EvoLV distinguishes itself by maintaining a rigorous focus on compliance, helping clients navigate the complex regulatory landscape with confidence. Their deep understanding of global regulations and standards ensures that clients remain compliant while pursuing innovative solutions.

By integrating compliance considerations into every aspect of their consulting services, EvoLV mitigates risks and enhances the overall sustainability of client operations. This proactive approach to compliance is a key factor in the company's reputation for reliability and trustworthiness.

Leveraging Data-Driven Insights

EvoLV recognizes the power of data in driving informed decision-making. The company utilizes advanced data analytics to uncover valuable insights, enabling clients to make strategic choices based on solid evidence. This data-driven approach enhances the precision and effectiveness of EvoLV's consulting services, providing clients with a competitive edge.

Through the integration of data analytics, EvoLV not only identifies opportunities for improvement but also measures the impact of implemented strategies. This commitment to continuous improvement ensures that clients receive measurable benefits from their partnership with EvoLV.

data analytics life sciences